SMS Lifesciences India Ltd

SMS Lifesciences Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

SMS Lifesciences India Ltd

₹ 1,308 -4.75%
30 May - close price
smslife.in BSE: 540679 NSE: SMSLIFE
About

Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates[1]

Key Points

Business Overview:[1][2][3]
Company is the demerged entity of SMS Pharmaceuticals Ltd, catering to semi-regulated markets across India, Europe, and Asia with a portfolio of 12 APIs in the GAS and Anti-erectile dysfunction (EDF) therapeutic segment. It does manufacturing of Antiulcerative products, for Indian and global markets and supplies KSMs and Intermediates

Website BSE NSE
  • Market Cap ₹ 396 Cr.
  • Current Price ₹ 1,308
  • High / Low ₹ 1,750 / 681
  • Stock P/E 18.5
  • Book Value ₹ 652
  • Dividend Yield 0.11 %
  • ROCE 13.9 %
  • ROE 11.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • The company has delivered a poor sales growth of 5.35% over past five years.
  • Company has a low return on equity of 8.65% over last 3 years.
  • Dividend payout has been low at 3.00% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
94.96 80.45 78.48 90.76 65.55 74.56 67.84 71.23 86.37 86.57 78.50 82.88 85.43
87.90 71.56 72.04 82.55 63.03 69.43 58.36 62.21 75.56 72.80 66.71 69.81 79.83
Operating Profit 7.06 8.89 6.44 8.21 2.52 5.13 9.48 9.02 10.81 13.77 11.79 13.07 5.60
OPM % 7.43% 11.05% 8.21% 9.05% 3.84% 6.88% 13.97% 12.66% 12.52% 15.91% 15.02% 15.77% 6.56%
6.15 0.30 0.13 0.50 4.64 0.58 0.33 0.64 2.28 0.43 1.26 0.06 2.20
Interest 1.24 1.18 1.24 1.26 1.41 1.82 2.48 2.04 2.56 2.16 1.92 1.96 1.84
Depreciation 1.97 1.99 2.04 2.03 2.12 2.53 2.55 2.55 2.62 2.50 2.57 2.56 2.62
Profit before tax 10.00 6.02 3.29 5.42 3.63 1.36 4.78 5.07 7.91 9.54 8.56 8.61 3.34
Tax % 15.60% 31.89% 20.06% 26.01% 31.96% 48.53% 34.73% 34.71% 24.91% 32.29% 29.79% 27.64% 19.76%
8.44 4.11 2.63 4.01 2.47 0.70 3.12 3.31 5.93 6.46 6.01 6.23 2.68
EPS in Rs 27.92 13.59 8.70 13.26 8.17 2.32 10.32 10.95 19.61 21.37 19.88 20.61 8.86
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 0 0 218 213 344 257 260 346 315 300 333
0 0 0 189 200 312 233 230 314 289 265 289
Operating Profit 0 0 0 28 13 33 24 30 31 26 35 44
OPM % 13% 6% 9% 9% 11% 9% 8% 12% 13%
0 0 0 2 3 2 2 1 14 5 4 4
Interest 0 0 0 6 4 5 5 5 5 5 9 8
Depreciation 0 0 0 6 6 6 7 7 8 8 10 10
Profit before tax 0 0 0 18 6 24 13 19 33 18 19 30
Tax % 30% -2% 30% 31% 32% 23% 28% 32% 29%
0 0 0 13 6 17 9 13 25 13 13 21
EPS in Rs 21.50 55.01 30.26 43.56 83.95 43.73 43.23 70.68
Dividend Payout % 0% 0% 3% 0% 3% 2% 3% 3% 2%
Compounded Sales Growth
10 Years: %
5 Years: 5%
3 Years: -1%
TTM: 11%
Compounded Profit Growth
10 Years: %
5 Years: 19%
3 Years: 10%
TTM: 81%
Stock Price CAGR
10 Years: %
5 Years: 37%
3 Years: 24%
1 Year: 72%
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 9%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.01 0.01 0.01 0.01 3 3 3 3 3 3 3 3
Reserves 0 -0 -0 82 85 102 110 123 148 161 173 194
0 0 0 26 27 47 50 45 62 87 92 82
0 0 0 67 61 98 66 101 99 86 79 80
Total Liabilities 0 0 0 175 177 251 229 272 312 337 347 358
0 0 0 73 69 88 94 101 99 140 138 150
CWIP 0 0 0 0 7 1 2 3 21 1 6 0
Investments 0 0 0 0 5 26 26 26 23 23 23 23
0 0 0 102 95 135 106 142 169 174 180 184
Total Assets 0 0 0 175 177 251 229 272 312 337 347 358

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 0 0 20 8 27 14 22 -15 5 15
0 0 0 -8 -7 -43 -13 -6 -7 -28 -14
0 0 0 -12 -1 18 -2 -8 15 23 -1
Net Cash Flow 0 0 0 -0 0 2 -1 8 -8 -1 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 65 46 39 31 42 36 53 60 71
Inventory Days 133 135 117 138 154 143 154 168 131
Days Payable 168 122 133 91 147 124 105 111 99
Cash Conversion Cycle 30 60 23 78 48 54 102 116 102
Working Capital Days 50 51 34 57 59 79 111 136 125
ROCE % 0% 0% 46% 9% 22% 12% 14% 13% 9% 10% 14%

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
69.85% 69.85% 70.32% 70.32% 70.32% 70.32% 70.68% 71.19% 71.40% 71.40% 71.40% 71.40%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.02% 0.00% 0.00%
30.15% 30.14% 29.69% 29.67% 29.68% 29.68% 29.31% 28.81% 28.59% 28.57% 28.59% 28.60%
No. of Shareholders 8,9398,7998,5938,3498,4758,4438,2338,1167,8617,8497,6267,479

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings